Results 191 to 200 of about 1,768,893 (247)

Trivalent Live-Attenuated Influenza Vaccine [PDF]

, 2020
openaire   +1 more source

Multicentre, prospective, single-arm, non-controlled, open-label trial to evaluate the safety and efficacy of live attenuated influenza vaccine in paediatric patients with atopic dermatitis undergoing dupilumab therapy: a protocol. [PDF]

BMJ Open
Kobayashi T, Sato H, Nagasawa K, Hayata E, Tanaka S, Kurihara E, Yamamoto T, Nakano T, Ozawa Y, Yamaide F, Inoue Y, Suzuki S, Arima T, Tomiita M, Hamada H, Ishiwada N.   +15 more
europepmc   +1 more source

Interactions between live attenuated influenza vaccine and nasopharyngeal microbiota among children aged 24-59 months in The Gambia: a phase 4, open-label, randomised controlled trial. [PDF]

Lancet Microbe
Peno C, Jagne YJ, Clerc M, Balcazar Lopez C, Armitage EP, Sallah H, Drammeh S, Senghore E, Goderski G, van Tol S, Meijer A, Ruiz-Rodriguez A, de Steenhuijsen Piters WAA, de Koff E, Jarju S, Lindsey BB, Camara J, Bah S, Mohammed NI, Kampmann B, Clarke E, Dockrell DH, de Silva TI, Bogaert D.   +23 more
europepmc   +1 more source

Quadrivalent Live-Attenuated Influenza Vaccine in Milan preschools: an Italian experience of school-located flu vaccination within the 2022-2023 season. [PDF]

Ital J Pediatr
Roncaglia S, Amendola A, Baldassarre P, Barilli F, Bianchi S, Biuso A, Chillemi C, Fappani C, Gasparini C, Gori M, Guida G, Ripoli F, Sgambetterra L, Tanzi E, Zuccotti GV.   +14 more
europepmc   +1 more source

Successes and Failures of the Live-attenuated Influenza Vaccine: Can We Do Better? [PDF]

Clin Infect Dis, 2020
Matrajt L, Halloran ME, Antia R.
europepmc   +1 more source

Development of Cross-Reactive Live Attenuated Influenza Vaccine Candidates against Both Lineages of Influenza B Virus. [PDF]

Vaccines (Basel)
Wong PF, Isakova-Sivak I, Stepanova E, Krutikova E, Bazhenova E, Rekstin A, Rudenko L.   +6 more
europepmc   +1 more source

Streptococcus pyogenescolonization in children aged 24-59 months in The Gambia: Impact of Live Attenuated Influenza Vaccine and associated serological responses

, 2022
Keeley AJ, Groves D, Armitage EP, Senghore E, Jagne YJ, Sallah HJ, Drammeh S, Angyal A, Hornsby H, de Crombrugghe G, Smeesters P, Rossi O, Carducci M, Peno C, Bogaert D, Kampmann B, Marks M, Shaw HA, Turner CE, de Silva TI.   +19 more
europepmc   +1 more source

Generation and Characterization of Universal Live-Attenuated Influenza Vaccine Candidates Containing Multiple M2e Epitopes. [PDF]

Vaccines (Basel), 2020
Kotomina T, Isakova-Sivak I, Kim KH, Park BR, Jung YJ, Lee Y, Mezhenskaya D, Matyushenko V, Kang SM, Rudenko L.   +9 more
europepmc   +1 more source

Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza. [PDF]

Virol J
Stepanova E, Isakova-Sivak I, Mezhenskaya D, Niskanen S, Matyushenko V, Bazhenova E, Rak A, Wong PF, Prokopenko P, Kotomina T, Krutikova E, Legotskiy S, Neterebskii B, Ostroukhova T, Sivak K, Orshanskaya Y, Yakovlev K, Rudenko L.   +17 more
europepmc   +1 more source